Present- Versus Past-focused Therapy for PTSD and Substance Use Disorder
NCT ID: NCT01274741
Last Updated: 2019-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2011-01-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating Supplementing Residential Substance Use Treatment With Written Exposure Therapy for Veterans With Post Traumatic Stress Disorder (PTSD) and Substance Use Disorders (SUD)
NCT05536908
Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment
NCT04581434
Combined Treatment for Patients With Comorbid Substance Use Disorders and Post-traumatic Stress Disorder (PTSD): an Integration of Cognitive-behavioral Treatment (CBT) and Trauma-focused Structured Writing Therapy
NCT00763542
Trauma-Focused Intervention With Women Experiencing Homelessness
NCT05873517
Written Exposure Therapy for Veterans With SUD and PTSD
NCT05327504
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Seeking Safety (SS)
17 sessions of present-focused therapy Seeking Safety
Seeking Safety (SS)
Seeking Safety is a present-focused, evidence-based cognitive-behavioral therapy for integrated treatment of patients with PTSD/SUD. It is a cognitive-behavioral therapy comprising 25 topics, each a coping skill relevant to both disorders. In this study 17 of the 25 topics were conducted, one per weekly, one-hour, individual session.
Creating Change (CC)
17 sessions of past-focused Creating Change
Creating Change (CC)
Creating Change is a past-focused, integrated, cognitive-behavioral therapy for PTSD/SUD. It has 17 topics, which in this study were delivered in weekly one-hour sessions, in individual format. The treatment explores how PTSD and SUD arose and interacted across the patient's life, including constructing a narrative of its meaning, processing associated emotions and memories, and exploring themes related to these.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Creating Change (CC)
Creating Change is a past-focused, integrated, cognitive-behavioral therapy for PTSD/SUD. It has 17 topics, which in this study were delivered in weekly one-hour sessions, in individual format. The treatment explores how PTSD and SUD arose and interacted across the patient's life, including constructing a narrative of its meaning, processing associated emotions and memories, and exploring themes related to these.
Seeking Safety (SS)
Seeking Safety is a present-focused, evidence-based cognitive-behavioral therapy for integrated treatment of patients with PTSD/SUD. It is a cognitive-behavioral therapy comprising 25 topics, each a coping skill relevant to both disorders. In this study 17 of the 25 topics were conducted, one per weekly, one-hour, individual session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have used a substance in the 60 days prior to intake
* Outpatient
* Plan to stay in Boston for the next 6 months
* If on psychiatric medication, are on a stable regimen for at least 4 weeks prior to participation in the study
* Have a stable mailing address and live nearby enough to come to VA Boston for treatment
* Able to sign informed consent
* Willing to participate in all assessments and urine testing
* Willing to provide a release of information for study staff to contact treaters as needed for clinical concerns
Exclusion Criteria
* Current bipolar I disorder, schizophrenia or other psychotic disorders, mental retardation, or organic mental disorder
* Any obvious clinical sign that the patient is not sufficiently stable to participate in the treatment, or notification by the patient's primary providers that participation would be contraindicated
* Dangerousness that would present a threat to staff or patients (e.g., history of assault within the past 6 months)
* The patient is mandated to treatment
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Boston Healthcare System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karen Krinsley
PTSD Section Chief
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen E. Krinsley, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
VA Boston Healthcare System
Lisa M Najavits, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Boston Healthcare System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Boston Healthcare System
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Najavits LM, Krinsley K, Waring ME, Gallagher MW, Skidmore C. A Randomized Controlled Trial for Veterans with PTSD and Substance Use Disorder: Creating Change versus Seeking Safety. Subst Use Misuse. 2018 Sep 19;53(11):1788-1800. doi: 10.1080/10826084.2018.1432653. Epub 2018 Feb 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPLA-CX000308-01 (VA CSRD)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.